BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [ChIP-Seq]
Ontology highlight
ABSTRACT: Hijacking of primitive hematopoietic enhancers, or generation of a neo-enhancer by genomic amplification, results in deregulation of BCL11B as the defining feature of a subset of T/myeloid leukemia. We report H3K27ac and BCL11B binding in these Leukemias.
ORGANISM(S): Homo sapiens
PROVIDER: GSE165016 | GEO | 2021/05/19
REPOSITORIES: GEO
ACCESS DATA
